Literature DB >> 16825882

Psychic stress and quality of life in parents during decisive phases in the therapy of their hearing-impaired children.

Thorsten Burger1, Claudia Spahn, Bernhard Richter, Susanne Eissele, Erwin Löhle, Jürgen Bengel.   

Abstract

OBJECTIVE: This study was performed to analyze psychic stress and quality of life in the parents of children with hearing impairment in the course of various phases of treatment.
DESIGN: At three measuring points over a course of 12 months, the degree of parental stress and the quality of life was surveyed prospectively. In addition, the children's hearing and speech status was surveyed. Parents whose children were treated with hearing aids or cochlear implants were the target of this survey. At the outset of the study, data of 123 parents were available. The average age of the children was 38 months.
RESULTS: It was not possible to demonstrate generally heightened psychic stress in any phase of treatment. Differentiation into subgroups must be performed, as parental stress depends on possible changes of treatment and the child's speech status. Initially, quality of life was clearly reduced but gradually became statistically insignificant.
CONCLUSIONS: The results point out the necessity of supporting the parents with counseling and psychosocial support, especially in the initial fitting phase and in the various decision and orientation phases.

Entities:  

Mesh:

Year:  2006        PMID: 16825882     DOI: 10.1097/01.aud.0000224733.53110.27

Source DB:  PubMed          Journal:  Ear Hear        ISSN: 0196-0202            Impact factor:   3.570


  2 in total

1.  A comparison of the quality of life of parents of children using hearing aids and those using cochlear implants.

Authors:  Saranya Arya Mundayoor; Prabuddha Bhatarai; Prashanth Prabhu
Journal:  J Otol       Date:  2022-07-06

Review 2.  Multidimensional Family-Centred Early Intervention in Children with Hearing Loss: A Conceptual Model.

Authors:  Daniel Holzinger; Johannes Hofer; Magdalena Dall; Johannes Fellinger
Journal:  J Clin Med       Date:  2022-03-11       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.